Spoken Alpha
CHEMED CORP
Chemed operates two business segments: VITAS, which provides hospice and palliative care services to patients through physicians, nurses, and other healthcare professionals, and Roto-Rooter, which provides plumbing, drain cleaning, excavation, water restoration, and related services to residential and commercial customers.
CHEMED CORP is a Healthcare company operating in Medical Care Facilities with a $6.74B market cap.
Most recent reported earnings: Q3 FY2026 (Oct 26, 2026).
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CHE.
$ curl https://api.spokenalpha.com/v1/companies/CHEFAQ
Spoken Alpha indexes CHE's earnings call transcripts at https://spokenalpha.com/companies/CHE. Each call links to attributed speakers and parsed analyst Q&A. CHEMED CORP's own investor relations page is at https://www.chemed.com/investor-relations/overview.
CHEMED CORP (CHE) held its most recent earnings call on 2026-07-29, covering fiscal Q2 2026.
CHEMED CORP (CHE) operates in the Healthcare sector (Medical Care Facilities industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-26 | — | $5.80 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-07-27 | $5.52 | $5.12 | +7.8% | $673.3M | — | — | EODHDDisagrees |
| Q1 FY2026 | 2026-04-22 | $5.65 | $5.30 | +6.6% | $657.5M | — | — | EODHD |
| Q4 FY2025 | 2026-02-24 | $6.42 | $7.07 | -9.2% | $639.3M | — | — | EODHD |
| Q3 FY2025 | 2025-10-27 | $5.27 | $5.37 | -1.9% | $624.9M | — | — | EODHD |
| Q2 FY2025 | 2025-07-28 | $4.27 | $4.98 | -14.3% | $618.8M | — | — | EODHD |
| Q1 FY2025 | 2025-04-22 | $5.63 | $5.55 | +1.4% | $646.9M | — | — | EODHD |
| Q4 FY2024 | 2025-02-24 | $6.83 | $6.79 | +0.6% | $640.0M | — | — | EODHD |
| Q3 FY2024 | 2024-10-28 | $5.64 | $5.76 | -2.1% | $606.2M | — | — | EODHD |
| Q2 FY2024 | 2024-07-23 | $5.47 | $5.59 | -2.1% | $595.9M | — | — | EODHD |
| Q1 FY2024 | 2024-04-23 | $5.20 | $5.48 | -5.1% | $589.2M | — | — | EODHD |
| Q4 FY2023 | 2024-02-26 | $6.60 | $6.25 | +5.6% | $585.9M | — | — | EODHD |
| Q3 FY2023 | 2023-10-24 | $5.32 | $4.90 | +8.6% | $564.5M | — | — | EODHD |
| Q2 FY2023 | 2023-07-25 | $4.71 | $5.09 | -7.5% | $553.8M | — | — | EODHD |
| Q1 FY2023 | 2023-04-25 | $4.82 | $4.81 | +0.2% | $560.2M | — | — | EODHD |
| Q4 FY2022 | 2023-02-22 | $5.39 | $5.32 | +1.3% | $546.7M | — | — | EODHD |
| Q3 FY2022 | 2022-10-30 | $4.74 | $4.65 | +1.9% | $526.5M | — | — | EODHD |
| Q2 FY2022 | 2022-07-26 | $4.84 | $4.78 | +1.3% | $531.3M | — | — | EODHD |
| Q1 FY2022 | 2022-04-25 | $4.79 | $4.47 | +7.2% | $530.5M | — | — | EODHD |
| Q4 FY2021 | 2022-02-23 | $5.25 | $5.08 | +3.4% | $541.0M | — | — | EODHD |
Source: EODHD. Some rows have cross-provider disagreement flags (see badge). CHE reported actuals as published; sparse fields render as —.